Latest
-
Depressing drug result for Astra
News An anti-depressant product made by Anglo-Swedish drugs titan AstraZeneca and US partner Targacept has failed to meet its initial target.
News -
Glaxo to pay $3bn to settle with US government
News Drugs giant GlaxoSmithKline is set to pay $3bn to get the US government off its back over the the company's sales and market practices in the past.
News -
A biotech startup already yielding 6.4%
Features Small, innovative companies that can sell their products around the world are exactly what Britain needs. And Tom Bulford's found an excellent example here, which he'll be keeping a very close eye on.
Features -
Could this be the next hot sector in the stock market?
Features 'Big pharma', faced with cut-price competition as patents expire, is cutting back on research. That's created big opportunities for innovative small-cap companies - and for investors, says Tom Bulford. Here, he explains why he thinks biotech could be the next hot market sector.
Features -
Why biotech will command the headlines this year
Features Big pharmaceutical companies need to develop new drugs to survive - but they are cutting back on essential research. That opens the way for small biotech companies to fill the gaps, says Tom Bulford. Here, he examines the industry's potential.
Features -
The biotech firm that soared in value nineteen-fold
Features Biotech is a sector on the cusp of a thrilling revival. Tom Bulford looks at several biotech shares including one that's seen its share price rise nineteen fold in just three days.
Features -
Three biotech penny shares to watch
Features Diabetes is on the rise. Companies working to counter its effects stand to make big profits. Here, Tom Bulford looks at three small-cap biotech companies aiming to do just that.
Features -
Four experimental biotech stocks
Features The field of 'regenerative medicine' has seen some incredible advances, and the market is set to take off, says Marc Lichtenfeld. Here, he explains how to play the sector and tips four potential winners.
Features